AR023616A1 - Preparaciones combinadas que comprenden derivados de antraciclina - Google Patents

Preparaciones combinadas que comprenden derivados de antraciclina

Info

Publication number
AR023616A1
AR023616A1 ARP000101989A ARP000101989A AR023616A1 AR 023616 A1 AR023616 A1 AR 023616A1 AR P000101989 A ARP000101989 A AR P000101989A AR P000101989 A ARP000101989 A AR P000101989A AR 023616 A1 AR023616 A1 AR 023616A1
Authority
AR
Argentina
Prior art keywords
anthracicline
derivatives
understanding
combined preparations
topoisomerase
Prior art date
Application number
ARP000101989A
Other languages
English (en)
Original Assignee
Nerviano Medical Sciences Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nerviano Medical Sciences Srl filed Critical Nerviano Medical Sciences Srl
Publication of AR023616A1 publication Critical patent/AR023616A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Preparaciones combinadas que comprenden una antraciclina de morfolinil administrada en combinacion con agentes anticancerígenos seleccionados entre unagente alquilizante, un anti-metabolito, un inhibidor de topoisomerasa II, un inhibidor de topoisomerasa I, una droga antimitotica y un derivado de platino, quson utiles como terapia anti-cancerígena, particularmente en el tratamiento de un cáncer de hígado primario o metastásico.
ARP000101989A 1999-04-29 2000-04-27 Preparaciones combinadas que comprenden derivados de antraciclina AR023616A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9909925.1A GB9909925D0 (en) 1999-04-29 1999-04-29 Combined preparations comprising anthracycline derivatives

Publications (1)

Publication Number Publication Date
AR023616A1 true AR023616A1 (es) 2002-09-04

Family

ID=10852508

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101989A AR023616A1 (es) 1999-04-29 2000-04-27 Preparaciones combinadas que comprenden derivados de antraciclina

Country Status (16)

Country Link
US (2) US6537990B1 (es)
EP (3) EP1977753A1 (es)
JP (1) JP2002543112A (es)
CN (5) CN1535688A (es)
AR (1) AR023616A1 (es)
AT (2) ATE246507T1 (es)
AU (1) AU4397700A (es)
DE (2) DE60004348T2 (es)
DK (1) DK1173187T3 (es)
ES (2) ES2307867T3 (es)
GB (1) GB9909925D0 (es)
HK (1) HK1045462B (es)
MY (1) MY136610A (es)
PT (1) PT1173187E (es)
TW (1) TWI222863B (es)
WO (1) WO2000066093A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9916882D0 (en) * 1999-07-19 1999-09-22 Pharmacia & Upjohn Spa Antitumor synergistic composition
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
US20030133939A1 (en) * 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
US7829084B2 (en) 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
EP1383490B1 (en) * 2001-03-14 2012-04-25 Bristol-Myers Squibb Company Combination of an epothilone analog and chemotherapeutic agents for the treatment of proliferative diseases
US20080075762A1 (en) * 2001-10-03 2008-03-27 Paul Tardi Compositions for delivery of drug combinations
CA2383259A1 (en) 2002-04-23 2003-10-23 Celator Technologies Inc. Synergistic compositions
CA2472578A1 (en) * 2002-01-24 2003-07-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Anti-cancer combination and use thereof
TWI323662B (en) * 2002-11-15 2010-04-21 Telik Inc Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
US20060264388A1 (en) * 2003-02-26 2006-11-23 Olga Valota Method for treating liver cancer by intrahepatic administration of nemorubicin
AU2004222527A1 (en) * 2003-03-18 2004-09-30 Pharmacia Italia Spa Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor
CN100500212C (zh) * 2005-04-06 2009-06-17 山东蓝金生物工程有限公司 一种抗实体肿瘤药物组合物
SI1912675T1 (sl) 2005-07-25 2014-07-31 Emergent Product Development Seattle, Llc zmanjšanje števila celic B z uporabo molekul, ki se specifično vežejo na CD37 in CD20
US7776832B2 (en) * 2006-04-21 2010-08-17 Gem Pharmaceuticals, Llc Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines
CA2654317A1 (en) 2006-06-12 2007-12-21 Trubion Pharmaceuticals, Inc. Single-chain multivalent binding proteins with effector function
US20090004134A1 (en) * 2006-09-08 2009-01-01 Obeid Michel Sarkis Kit for treating a health condition by inducing translocation of an erp57 protein to a cellular membrane
WO2008092796A1 (en) * 2007-01-29 2008-08-07 Nerviano Medical Sciences S.R.L. Antitumor combination comprising a morpholinyl anthracycline and an antibody
US8940334B2 (en) 2007-05-11 2015-01-27 Nerviano Medical Sciences S.R.L. Pharmaceutical composition of an anthracycline
EP2257310A2 (en) * 2008-02-26 2010-12-08 Nerviano Medical Sciences S.r.l. Antitumor combination comprising a morpholinyl anthracycline derivative and demethylating agents
PT2132228E (pt) * 2008-04-11 2011-10-11 Emergent Product Dev Seattle Imunoterapia de cd37 e sua combinação com um quimioterápico bifuncional
US8690833B2 (en) 2011-01-31 2014-04-08 Vascular Pathways, Inc. Intravenous catheter and insertion device with reduced blood spatter
AU2015371308A1 (en) 2014-12-23 2017-08-03 Intellectual Property Associates, Llc Methods and formulations for transdermal administration
EP3352760A4 (en) 2015-09-21 2019-03-06 Aptevo Research and Development LLC CD3 BINDING POLYPEPTIDES
US20190083527A1 (en) 2017-09-15 2019-03-21 Ampersand Biopharmaceuticals, Inc. Method of administration and treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710564A (en) * 1985-01-18 1987-12-01 Microbial Chemistry Research Foundation Anthracycline compounds
GB2172594B (en) * 1985-03-22 1988-06-08 Erba Farmitalia New morpholino derivatives of daunorubicin and doxorubicin
US5902809A (en) * 1997-07-03 1999-05-11 Paracure, Inc. Arglabin compounds and therapeutic uses thereof
GB9806324D0 (en) * 1998-03-24 1998-05-20 Pharmacia & Upjohn Spa Antitumour synergetic composition
GB9820012D0 (en) * 1998-09-14 1998-11-04 Pharmacia & Upjohn Spa Use of an anthracycline derivative for the treatment of a liver tumor

Also Published As

Publication number Publication date
EP1173187B1 (en) 2003-08-06
CN1535688A (zh) 2004-10-13
DE60004348D1 (de) 2003-09-11
CN1222294C (zh) 2005-10-12
CN1853645A (zh) 2006-11-01
HK1045462B (zh) 2006-04-28
CN1507869A (zh) 2004-06-30
EP1323423A1 (en) 2003-07-02
EP1173187A2 (en) 2002-01-23
DK1173187T3 (da) 2003-10-20
CN1349406A (zh) 2002-05-15
AU4397700A (en) 2000-11-17
MY136610A (en) 2008-10-31
DE60039260D1 (de) 2008-07-31
WO2000066093A2 (en) 2000-11-09
ES2307867T3 (es) 2008-12-01
ATE246507T1 (de) 2003-08-15
ATE398457T1 (de) 2008-07-15
EP1977753A1 (en) 2008-10-08
HK1045462A1 (en) 2002-11-29
US6537990B1 (en) 2003-03-25
CN1853642A (zh) 2006-11-01
JP2002543112A (ja) 2002-12-17
EP1323423B1 (en) 2008-06-18
US6586428B2 (en) 2003-07-01
TWI222863B (en) 2004-11-01
PT1173187E (pt) 2003-10-31
GB9909925D0 (en) 1999-06-30
DE60004348T2 (de) 2004-02-26
US20030087839A1 (en) 2003-05-08
ES2204572T3 (es) 2004-05-01
WO2000066093A3 (en) 2001-01-25

Similar Documents

Publication Publication Date Title
AR023616A1 (es) Preparaciones combinadas que comprenden derivados de antraciclina
UY27943A1 (es) Composiciones y mctodos para tratar el crncer usando inmunoconjugados de anticuerpo para cd44 citotnxicos y agentes quimioterapcuticos
TR200102005T2 (tr) Poli(adp-ribaz) polimerazların trisiklik inhibitörleri.
CY1105225T1 (el) Παραγωγα 5-β-σαπωγενινης και ψευδοσαπωγενινης και η χρηση τους στην αντιμετωπιση ανοιας
NO20054988D0 (no) Preparater og metoder for behandling av cancer
AR027355A1 (es) Acidos tiazolidincarboxilicos
NO983669L (no) Coralyne analoger som topoisomeraseinhibitorer
BR0008453A (pt) Composição sinergìstica anti-tumoral
ATE444309T1 (de) Immuntherapie für kronische myelozytische leukämie mit nacktem anti-nca-90 antikörper
CY1107906T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει παραγωγα οιστετρολης για χρηση στην θεραπεια κατα του καρκινου
WO2004050033A3 (en) Method of treating cancers
AU2001273983A1 (en) Novel prodrugs von 6-hydroxy-2,3-dihydro-1h-indoles, 5-hydroxy-1,2-dihydro-3h-pyrrolo(3,2-e)indoles and 5-hydroxy-1,2-dihydro-3h-benzo(e)indoles as well as of 6-hydroxy-1,2,3,4-tetrahydro-benzo(f)quinoline derivatives for use in selective cancer therapy
UY26456A1 (es) Compuestos que fijan la estructura g-cuadruplex de los telomeros, triazinas de aplicación de dichos compuestos, la utilización de dichos compuestos como productos farmacéuticos y las asociaciones terapéuticas que los incluyen.
WO2001078783A3 (en) Compositions comprising natural agents for treatment of cancer
BR9908391A (pt) Composição antitumural contendo uma combinação sinergìstica de um derivado de antraciclina com um derivado de camptotecina
ECSP034766A (es) Una combinacion que comprende combretastatina y agentes anticancerigenos
TR200103271T2 (tr) İnflamasyon aracılığıyla gerçekleşen infeksiyon için anti-inflamatuar tedavi.
ES2188995T3 (es) Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
HUP0203153A2 (hu) Kombinációs kemoterápia
DK1276482T3 (da) Kombinationskemoterapi
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
MXPA03003798A (es) Derivados triciclicos de indol con actividad antiangiogenica.
EP1691801A4 (en) SYNERGISTIC ANTICANCER COMPOSITIONS
AU4558201A (en) Taxane anticancer agents
AR027677A1 (es) Una composicion farmaceutica terapeutica que comprende camptotecina y ciclofosfamida para el tratamiento del cancer

Legal Events

Date Code Title Description
FB Suspension of granting procedure